erythromycin has been researched along with transforming growth factor beta in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 8 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, B; Li, Y; Wang, H | 1 |
Chen, J; He, B; Li, Y; Wang, G; Zhang, W | 1 |
Dakhama, A; Gelfand, EW; Kraft, M; Martin, RJ | 1 |
Huang, JQ; Xie, CM | 1 |
Bai, J; Feng, ZB; Liang, GR; Shi, HZ; Wu, C; Zhong, XN | 1 |
Liu, J; Lu, XY; Shen, HH; Wu, DQ | 1 |
Makino, H; Nagase, R; Nishishita, S; Ogawa, D; Ohga, S; Okada, S; Sasaki, M; Shikata, K; Shikata, Y; Tone, A; Usui, H; Wada, J; Yozai, K | 1 |
Huang, JQ; Light, RW; Xie, C | 1 |
Abe, S; Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudoh, S; Li, YJ; Matsuda, K; Omura, S; Shimizu, T; Sunazuka, T; Takahashi, S; Usuki, J | 1 |
Abe, S; Azuma, A; Kudoh, S; Li, Y; Matsuda, K; Omura, S; Sunazuka, T; Usuki, J; Wang, C; Yu, C | 1 |
10 other study(ies) available for erythromycin and transforming growth factor beta
Article | Year |
---|---|
[The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Cytokines; Disease Models, Animal; Erythromycin; Gene Expression; Interleukin-1; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1999 |
[An experimental study on the effect of azithromycin treatment in bleomycin-induced pulmonary fibrosis of rats].
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Erythromycin; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1999 |
Induction of regulated upon activation, normal T cells expressed and secreted (RANTES) and transforming growth factor-beta 1 in airway epithelial cells by Mycoplasma pneumoniae.
Topics: Asthma; Bronchi; Cell Adhesion; Cell Line; Cells, Cultured; Chemokine CCL5; Cytokines; Dexamethasone; DNA Primers; Dose-Response Relationship, Drug; Endotoxins; Epithelial Cells; Erythromycin; Glucocorticoids; Humans; Kinetics; Mycoplasma; Mycoplasma pneumoniae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
[The effects of erythromycin on the secretion of tumor necrosis factor-alpha and transforming growth factor-beta1 and expression of connexin 43 in human pleural mesothelial cells].
Topics: Cells, Cultured; Connexins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Erythromycin; Humans; Pleura; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2003 |
[An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema].
Topics: Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Erythromycin; Hyaluronic Acid; Male; Muscle, Smooth, Vascular; Procollagen; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Radioimmunoassay; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
[The expression of transforming growth factor beta-1 in rat model of chronic obstructive pulmonary disease and the effects of early drugs intervention].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Drugs, Chinese Herbal; Erythromycin; Male; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Erythromycin; Intercellular Adhesion Molecule-1; Kidney; Macrophages; NF-kappa B; Rats; Rats, Sprague-Dawley; Streptozocin; Transcription Factor RelA; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
The effects of erythromycin on the viability and the secretion of TNF-alpha and TGF-beta1 and expression of connexin43 by human pleural mesothelial cells.
Topics: Analysis of Variance; Cell Survival; Cells, Cultured; Connexin 43; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Pleura; Pleurodesis; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2005 |
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Topics: Animals; Anti-Inflammatory Agents; Base Sequence; Bleomycin; Cell Line; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Lung; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Pulmonary Fibrosis; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta | 2006 |
EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts.
Topics: Anti-Bacterial Agents; Antifibrinolytic Agents; Cell Line; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Erythromycin; Fibroblasts; Gene Expression; Humans; Phosphorylation; RNA, Messenger; Smad Proteins; Transforming Growth Factor beta | 2008 |